326 related articles for article (PubMed ID: 29493134)
21. Research progress of astragaloside IV in the treatment of atopic diseases.
Yu S; Peng W; Qiu F; Zhang G
Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656
[TBL] [Abstract][Full Text] [Related]
22. Effect of cilostazol in treating diabetes-associated microvascular complications.
Asal NJ; Wojciak KA
Endocrine; 2017 May; 56(2):240-244. PubMed ID: 28293857
[TBL] [Abstract][Full Text] [Related]
23. Astragaloside IV relieves gestational diabetes mellitus in genetic mice through reducing hepatic gluconeogenesis.
Zhang R; Xing B; Zhao J; Zhang X; Zhou L; Yang S; Wang Y; Yang F
Can J Physiol Pharmacol; 2020 Jul; 98(7):466-472. PubMed ID: 32160476
[TBL] [Abstract][Full Text] [Related]
24. Astragaloside IV: A promising natural neuroprotective agent for neurological disorders.
Yao M; Zhang L; Wang L
Biomed Pharmacother; 2023 Mar; 159():114229. PubMed ID: 36652731
[TBL] [Abstract][Full Text] [Related]
25. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
26. Potential role of Rho kinase inhibitors in combating diabetes-related complications including diabetic neuropathy--a review.
Mishra RK; Alokam R; Sriram D; Yogeeswari P
Curr Diabetes Rev; 2013 May; 9(3):249-66. PubMed ID: 23506376
[TBL] [Abstract][Full Text] [Related]
27. Diabetes mellitus--overview.
Hoogwerf BJ; Sferra J; Donley BG
Foot Ankle Clin; 2006 Dec; 11(4):703-15. PubMed ID: 17097511
[TBL] [Abstract][Full Text] [Related]
28. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
Ju Y; Su Y; Chen Q; Ma K; Ji T; Wang Z; Li W; Li W
Biomed Pharmacother; 2019 Jan; 109():84-92. PubMed ID: 30396095
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of Huangqi (Astragalus membranaceus) and Chinese Yam (Rhizoma Dioscoreae) for Diabetic Nephropathy.
Wang C; Li S; Meng J; Xia M; Bo Q; Ying W
Altern Ther Health Med; 2023 Nov; 29(8):840-845. PubMed ID: 37856796
[TBL] [Abstract][Full Text] [Related]
31. An updated role of astragaloside IV in heart failure.
Zang Y; Wan J; Zhang Z; Huang S; Liu X; Zhang W
Biomed Pharmacother; 2020 Jun; 126():110012. PubMed ID: 32213428
[TBL] [Abstract][Full Text] [Related]
32. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
33. A review on protective role of genistein against oxidative stress in diabetes and related complications.
Weng L; Zhang F; Wang R; Ma W; Song Y
Chem Biol Interact; 2019 Sep; 310():108665. PubMed ID: 31125535
[TBL] [Abstract][Full Text] [Related]
34. Research progress on anti-diabetic Chinese medicines.
Li YJ; Xu HX
Zhong Yao Cai; 2006 Jun; 29(6):621-4. PubMed ID: 17039886
[TBL] [Abstract][Full Text] [Related]
35. Research progress of traditional Chinese medicine monomer in treating diabetic peripheral neuropathy: A review.
Xiaoqin S; Yi T; Xiaoyu L; Ya B; Jingwen S; Yin L
Medicine (Baltimore); 2024 Mar; 103(13):e37767. PubMed ID: 38552033
[TBL] [Abstract][Full Text] [Related]
36. Research progress on the antitumor effects of astragaloside IV.
Zhou R; Guo T; Li J
Eur J Pharmacol; 2023 Jan; 938():175449. PubMed ID: 36473596
[TBL] [Abstract][Full Text] [Related]
37. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications.
Huang DD; Shi G; Jiang Y; Yao C; Zhu C
Biomed Pharmacother; 2020 May; 125():109767. PubMed ID: 32058210
[TBL] [Abstract][Full Text] [Related]
38. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein.
Huang H; Lai S; Wan Q; Qi W; Liu J
Can J Physiol Pharmacol; 2016 May; 94(5):542-53. PubMed ID: 27070866
[TBL] [Abstract][Full Text] [Related]
39. Effects of Astragalus membranaceus-based Chinese Medicine Formulae on Residual Renal Function in Patients on Peritoneal Dialysis.
Lui SL; Zhu D; Cheng SW; Ng F; Hui PC; Yip T; Lo WK
Perit Dial Int; 2015; 35(5):595-7. PubMed ID: 26450483
[No Abstract] [Full Text] [Related]
40. Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review.
Zhang Z; Zhang L; Xu H
J Tradit Chin Med; 2019 Feb; 39(1):133-138. PubMed ID: 32186034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
